Composition
- Active ingredients
- CISPLATIN 1MG/ML
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- CISPLATIN 1MG/ML · InjectableNDA018057-004 · Prescription
- CISPLATIN 50MG/VIAL · InjectableNDA018057-002 · Prescription
- CISPLATIN 1MG/ML · InjectableANDA206774-001 · Prescription
- CISPLATIN 1MG/ML · InjectableANDA207323-001 · Prescription
- CISPLATIN 1MG/ML · InjectableANDA218868-001 · Prescription
- CISPLATIN 1MG/ML · InjectableANDA075036-001 · Prescription
- CISPLATIN 1MG/ML · InjectableANDA091062-001 · Discontinued
- CISPLATIN 1MG/ML · InjectableANDA074656-001 · Prescription
- CISPLATIN 10MG/VIAL · InjectableANDA074713-001 · Discontinued
- CISPLATIN 50MG/VIAL · InjectableANDA074713-002 · Discontinued
- CISPLATIN 1MG/ML · InjectableANDA074814-001 · Discontinued
- CISPLATIN 1MG/ML · InjectableThis page
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA074735.
At a glance
- Brand name
- Cisplatin
- Route
- Injection
- Dosage form
- Injectable
- Applicant
- Fresenius Kabi USA
- Status
- Prescription
- FDA approval
- 16 Jul 1999
- Application
- ANDA074735-001